A comparative, randomized clinical trial of artemisinin/naphtoquine twice daily one day versus artemether/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire

BACKGROUND: Drug resistance in Plasmodium falciparum poses a major threat to malaria control. Combination anti-malarial therapy, including artemisinins, has been advocated to improve efficacy and limit the spread of resistance. The fixed combination of oral artemether-lumefantrine (AL) is highly eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Toure, Offianan A, Penali, Louis K, Yapi, Jean-Didier, Ako, Berenger A, Toure, Walamtchin, Djerea, Kali, Gomez, Genevieve O, Makaila, Oyewole
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714523/
https://www.ncbi.nlm.nih.gov/pubmed/19575797
http://dx.doi.org/10.1186/1475-2875-8-148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714523/
https://www.ncbi.nlm.nih.gov/pubmed/19575797
http://dx.doi.org/10.1186/1475-2875-8-148

Ejemplares similares